Clinical Implications of Burkitt Lymphoma View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2012-10-27

AUTHORS

Jakub Svoboda , Stephen J. Schuster

ABSTRACT

Patients with Burkitt lymphoma present a unique challenge to clinicians because of the highly aggressive nature of this neoplasm. Three variants of Burkitt lymphoma are recognized: endemic, sporadic, and immunodeficiency-related [1]. While the epidemiology and some clinical characteristics differ among subtypes, the unifying features are rapid tumor cell growth and a propensity to involve extranodal sites. This chapter will focus on the clinical consequences of these biologic features, which frequently present as oncologic emergencies. These aspects of Burkitt lymphoma need to be readily recognized by physicians caring for these patients since delays in providing optimal therapy can result in poor outcome and early mortality. More... »

PAGES

67-80

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-4614-4313-1_4

DOI

http://dx.doi.org/10.1007/978-1-4614-4313-1_4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1052389174


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, 3400 Civic Center Blvd., 19104, Philadelphia, PA, USA", 
          "id": "http://www.grid.ac/institutes/grid.412701.1", 
          "name": [
            "Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, 3400 Civic Center Blvd., 19104, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Svoboda", 
        "givenName": "Jakub", 
        "id": "sg:person.0722677225.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722677225.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, 3400 Civic Center Blvd., 19104, Philadelphia, PA, USA", 
          "id": "http://www.grid.ac/institutes/grid.412701.1", 
          "name": [
            "Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, 3400 Civic Center Blvd., 19104, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schuster", 
        "givenName": "Stephen J.", 
        "id": "sg:person.011060364477.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011060364477.44"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2012-10-27", 
    "datePublishedReg": "2012-10-27", 
    "description": "Patients with Burkitt lymphoma present a unique challenge to clinicians because of the highly aggressive nature of this neoplasm. Three variants of Burkitt lymphoma are recognized: endemic, sporadic, and immunodeficiency-related [1]. While the epidemiology and some clinical characteristics differ among subtypes, the unifying features are rapid tumor cell growth and a propensity to involve extranodal sites. This chapter will focus on the clinical consequences of these biologic features, which frequently present as oncologic emergencies. These aspects of Burkitt lymphoma need to be readily recognized by physicians caring for these patients since delays in providing optimal therapy can result in poor outcome and early mortality.", 
    "editor": [
      {
        "familyName": "Robertson", 
        "givenName": "Erle S.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-4614-4313-1_4", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-4614-4312-4", 
        "978-1-4614-4313-1"
      ], 
      "name": "Burkitt\u2019s Lymphoma", 
      "type": "Book"
    }, 
    "keywords": [
      "Burkitt's lymphoma", 
      "tumor cell growth", 
      "oncologic emergency", 
      "clinical characteristics", 
      "extranodal sites", 
      "lymphoma presents", 
      "optimal therapy", 
      "poor outcome", 
      "early mortality", 
      "rapid tumor cell growth", 
      "biologic features", 
      "clinical consequences", 
      "aggressive nature", 
      "clinical implications", 
      "patients", 
      "lymphoma", 
      "cell growth", 
      "neoplasms", 
      "unique challenges", 
      "therapy", 
      "mortality", 
      "clinicians", 
      "epidemiology", 
      "subtypes", 
      "physicians", 
      "outcomes", 
      "unifying feature", 
      "emergency", 
      "variants", 
      "features", 
      "propensity", 
      "need", 
      "consequences", 
      "sites", 
      "delay", 
      "present", 
      "implications", 
      "challenges", 
      "growth", 
      "characteristics", 
      "aspects", 
      "chapter", 
      "nature"
    ], 
    "name": "Clinical Implications of Burkitt Lymphoma", 
    "pagination": "67-80", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1052389174"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-4614-4313-1_4"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-4614-4313-1_4", 
      "https://app.dimensions.ai/details/publication/pub.1052389174"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-05-20T07:42", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/chapter/chapter_167.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-1-4614-4313-1_4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-4614-4313-1_4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-4614-4313-1_4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-4614-4313-1_4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-4614-4313-1_4'


 

This table displays all metadata directly associated to this object as RDF triples.

110 TRIPLES      23 PREDICATES      67 URIs      60 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-4614-4313-1_4 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N59bd32efcaa7472baaa34f63c3b1b9ba
4 schema:datePublished 2012-10-27
5 schema:datePublishedReg 2012-10-27
6 schema:description Patients with Burkitt lymphoma present a unique challenge to clinicians because of the highly aggressive nature of this neoplasm. Three variants of Burkitt lymphoma are recognized: endemic, sporadic, and immunodeficiency-related [1]. While the epidemiology and some clinical characteristics differ among subtypes, the unifying features are rapid tumor cell growth and a propensity to involve extranodal sites. This chapter will focus on the clinical consequences of these biologic features, which frequently present as oncologic emergencies. These aspects of Burkitt lymphoma need to be readily recognized by physicians caring for these patients since delays in providing optimal therapy can result in poor outcome and early mortality.
7 schema:editor Ne7b96f0fb41c4eac8deb17af058330da
8 schema:genre chapter
9 schema:inLanguage en
10 schema:isAccessibleForFree false
11 schema:isPartOf Nc9c2a5ca3df7416cbf12fc063b561cd7
12 schema:keywords Burkitt's lymphoma
13 aggressive nature
14 aspects
15 biologic features
16 cell growth
17 challenges
18 chapter
19 characteristics
20 clinical characteristics
21 clinical consequences
22 clinical implications
23 clinicians
24 consequences
25 delay
26 early mortality
27 emergency
28 epidemiology
29 extranodal sites
30 features
31 growth
32 implications
33 lymphoma
34 lymphoma presents
35 mortality
36 nature
37 need
38 neoplasms
39 oncologic emergency
40 optimal therapy
41 outcomes
42 patients
43 physicians
44 poor outcome
45 present
46 propensity
47 rapid tumor cell growth
48 sites
49 subtypes
50 therapy
51 tumor cell growth
52 unifying feature
53 unique challenges
54 variants
55 schema:name Clinical Implications of Burkitt Lymphoma
56 schema:pagination 67-80
57 schema:productId N81a4618e78684bb2b29f0ef9bb46b7b3
58 Nbbdf529f007a4f199700a79fb55adfe9
59 schema:publisher Nb0b1983809a94edd8c112242d1900b47
60 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052389174
61 https://doi.org/10.1007/978-1-4614-4313-1_4
62 schema:sdDatePublished 2022-05-20T07:42
63 schema:sdLicense https://scigraph.springernature.com/explorer/license/
64 schema:sdPublisher N73b4866db4fe4c21a69b30c86e9057cb
65 schema:url https://doi.org/10.1007/978-1-4614-4313-1_4
66 sgo:license sg:explorer/license/
67 sgo:sdDataset chapters
68 rdf:type schema:Chapter
69 N59bd32efcaa7472baaa34f63c3b1b9ba rdf:first sg:person.0722677225.98
70 rdf:rest Ndadc25ee4a8a41dfa8fcf3108d29162d
71 N73b4866db4fe4c21a69b30c86e9057cb schema:name Springer Nature - SN SciGraph project
72 rdf:type schema:Organization
73 N81a4618e78684bb2b29f0ef9bb46b7b3 schema:name doi
74 schema:value 10.1007/978-1-4614-4313-1_4
75 rdf:type schema:PropertyValue
76 Nb0b1983809a94edd8c112242d1900b47 schema:name Springer Nature
77 rdf:type schema:Organisation
78 Nbbdf529f007a4f199700a79fb55adfe9 schema:name dimensions_id
79 schema:value pub.1052389174
80 rdf:type schema:PropertyValue
81 Nc9c2a5ca3df7416cbf12fc063b561cd7 schema:isbn 978-1-4614-4312-4
82 978-1-4614-4313-1
83 schema:name Burkitt’s Lymphoma
84 rdf:type schema:Book
85 Ndadc25ee4a8a41dfa8fcf3108d29162d rdf:first sg:person.011060364477.44
86 rdf:rest rdf:nil
87 Ne3449218643b431fb2297fc0cc97f852 schema:familyName Robertson
88 schema:givenName Erle S.
89 rdf:type schema:Person
90 Ne7b96f0fb41c4eac8deb17af058330da rdf:first Ne3449218643b431fb2297fc0cc97f852
91 rdf:rest rdf:nil
92 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
93 schema:name Medical and Health Sciences
94 rdf:type schema:DefinedTerm
95 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
96 schema:name Oncology and Carcinogenesis
97 rdf:type schema:DefinedTerm
98 sg:person.011060364477.44 schema:affiliation grid-institutes:grid.412701.1
99 schema:familyName Schuster
100 schema:givenName Stephen J.
101 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011060364477.44
102 rdf:type schema:Person
103 sg:person.0722677225.98 schema:affiliation grid-institutes:grid.412701.1
104 schema:familyName Svoboda
105 schema:givenName Jakub
106 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722677225.98
107 rdf:type schema:Person
108 grid-institutes:grid.412701.1 schema:alternateName Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, 3400 Civic Center Blvd., 19104, Philadelphia, PA, USA
109 schema:name Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, 3400 Civic Center Blvd., 19104, Philadelphia, PA, USA
110 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...